Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
517,348,570
-
Share change
-
+11,155,408
-
Total reported value
-
$29,742,656,502
-
Put/Call ratio
-
78%
-
Price per share
-
$57.51
-
Number of holders
-
811
-
Value change
-
+$654,033,289
-
Number of buys
-
327
-
Number of sells
-
337
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q4 2014
As of 31 Dec 2014,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
811 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
517,348,570 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, FMR LLC, Capital Research Global Investors, Invesco Ltd., LAZARD ASSET MANAGEMENT LLC, WADDELL & REED FINANCIAL INC, Allianz Asset Management AG, Mondrian Investment Partners LTD, BARROW HANLEY MEWHINNEY & STRAUSS LLC, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
812
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.